Related Experiment Video
Updated: Jun 17, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Cryptic aspergillosis: a rare entity and a diagnostic challenge
Lavanya R1, Marilyn M Ninan1, Regi Kurien2
1Department of Clinical Microbiology, Christian Medical College, Vellore 632004, India.
Introduction:
Cryptic aspergillosis, caused by cryptic species of Aspergillus, is increasingly reported in humans and causes significant morbidity and mortality in immunocompromised individuals. The main aim of this study was to describe the occurrence of this entity at a large tertiary care centre and analyse the challenges in identifying them in a routine diagnostic laboratory.
Methods:
This was a retrospective case review of all patients diagnosed with cryptic Aspergillus species from April 2019 to February 2020. The isolates were identified using conventional microbiological techniques, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI- TOF MS), 28S rRNA and internal transcribed spacer (ITS) sequencing.
Results:
The species identified were Aspergillus tamarii, Aspergillus lentulus and Aspergillus sydowii. Identification by MALDI- TOF MS and sequencing was concordant for all except A. sydowii, with MALDI- TOF MS misidentifying it as Aspergillus thermomutans. All isolates showed low minimum inhibitory concentrations (MICs) for the panel of antifungal drugs.
Conclusion:
Aspergillosis caused by cryptic Aspergillus species presents a diagnostic challenge. This study confirms the importance of molecular methods for accurate identification.
Insights
Cryptic aspergillosis, caused by challenging-to-identify Aspergillus species, requires advanced molecular methods for accurate diagnosis. This study highlights the diagnostic difficulties and emphasizes the need for precise identification in clinical settings.
Area of Science:
- Medical Mycology
- Clinical Microbiology
- Infectious Diseases
Background:
- Cryptic aspergillosis, emerging from cryptic Aspergillus species, poses a significant threat to immunocompromised individuals.
- Accurate identification of these fungal pathogens is crucial for effective patient management and treatment.
Observation:
- This retrospective study reviewed cryptic Aspergillus infections diagnosed between April 2019 and February 2020 at a tertiary care center.
- Conventional methods, MALDI-TOF MS, and molecular sequencing (28S rRNA and ITS) were employed for isolate identification.
- Identified species included Aspergillus tamarii, Aspergillus lentulus, and Aspergillus sydowii.
Findings:
- MALDI-TOF MS and sequencing showed concordance for most isolates, but misidentified Aspergillus sydowii as Aspergillus thermomutans.
- All identified cryptic Aspergillus isolates exhibited low minimum inhibitory concentrations (MICs) to antifungal drugs.
- Cryptic Aspergillus species present considerable diagnostic challenges in routine laboratory settings.
Implications:
- Accurate identification of cryptic Aspergillus species is essential for appropriate antifungal therapy selection.
- Molecular identification methods are critical for overcoming the limitations of conventional techniques and mass spectrometry.
- Enhanced diagnostic strategies are needed to improve patient outcomes in cases of cryptic aspergillosis.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Fungal Phylum Ascomycota
Atypical Pneumonia
Cryptococcal Meningitis
Toxoplasmosis
Brain Abscess l: Introduction

